Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphanie Hostenbach

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Pharmacology|January 24, 2020
Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple SclerosisStéphanie Hostenbach, Miguel D'Haeseleer, Ron Kooijman, et al.
Progress in Neurobiology|May 3, 2016
The pathophysiological role of astrocytic endothelin-1Stéphanie Hostenbach, Miguel D'haeseleer, Ron Kooijman, et al.
Frontiers in Neurology|August 9, 2020
The Role of Cerebral Hypoperfusion in Multiple Sclerosis (ROCHIMS) Trial in Multiple Sclerosis: Insights From Negative ResultsStéphanie Hostenbach, Hubert Raeymaekers, Peter Van Schuerbeek, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 25, 2015
Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?Miguel D'haeseleer, Stéphanie Hostenbach, Ilse Peeters, et al.
Trials|March 16, 2019
Role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS): study protocol for a proof-of-concept randomized controlled trial with bosentanStéphanie Hostenbach, Ayla Pauwels, Veronique Michiels, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Pharmacology|January 24, 2020
Modulation of Cytokine-Induced Astrocytic Endothelin-1 Production as a Possible New Approach to the Treatment of Multiple SclerosisStéphanie Hostenbach, Miguel D'Haeseleer, Ron Kooijman, et al.
Progress in Neurobiology|May 3, 2016
The pathophysiological role of astrocytic endothelin-1Stéphanie Hostenbach, Miguel D'haeseleer, Ron Kooijman, et al.
Frontiers in Neurology|August 9, 2020
The Role of Cerebral Hypoperfusion in Multiple Sclerosis (ROCHIMS) Trial in Multiple Sclerosis: Insights From Negative ResultsStéphanie Hostenbach, Hubert Raeymaekers, Peter Van Schuerbeek, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 25, 2015
Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?Miguel D'haeseleer, Stéphanie Hostenbach, Ilse Peeters, et al.
Trials|March 16, 2019
Role of cerebral hypoperfusion in multiple sclerosis (ROCHIMS): study protocol for a proof-of-concept randomized controlled trial with bosentanStéphanie Hostenbach, Ayla Pauwels, Veronique Michiels, et al.
Pageof 1